Tumour heterogeneity studies based on dedicated breast PET using proliferation radiotracers: early detection of the treatment response.

Phase 1/2

Not yet recruiting

• Conditions: Breast cancer

• Registration Number: 2024-512152-38-00
• Lead Sponsor: Fundacion Instituto De Investigacion Sanitaria De Santiago De Compostela

Brief Summary

Not available

Detailed Description

Not available

Study Timeline

• Study First Posted: 2024-11-15
• Last Update Posted: 2024-11-15

Recruitment & Eligibility

• Status: Authorised, recruitment pending
• Sex: Female
• Target Recruitment: 100

Inclusion Criteria

-Adult women with breast cancer whose therapeutic plan is neoadjuvant chemotherapy
-Negative pregnancy test
-Information Sheet and Informed Consent Form signed by the patient
Are the trial subjects under 18? no
Number of subjects for this age range:
F.1.2 Adults (18-64 years) yes
F.1.2.1 Number of subjects for this age range 175
F.1.3 Elderly (>=65 years) no
F.1.3.1 Number of subjects for this age range

Exclusion Criteria

-Healthy women
-Women with breast cancer under 18
-Diabetic women with breast cancer
-Pregnant women with breast cancer
-Breast feeding women with breast cancer
-Women with breast cancer who have undergone a surgical procedure
-Women with breast cancer who have received chemotherapy or radiotherapy before the beginning of the study

Study & Design

• Study Type: Interventional clinical trial of medicinal product
• Study Design: Not specified

Trial Locations

Locations (1)

Complexo Hospitalario Universitario De Santiago; 🇪🇸 Santiago De Compostela, Spain

Complexo Hospitalario Universitario De Santiago

🇪🇸Santiago De Compostela, Spain

Virginia Pubul Núñez

Site contact

+34981951430

virginia.pubul.nunez@sergas.es